SEC Form 4 · accession 0001179110-15-007166
GILEAD SCIENCES, INC. · GILD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robin L Washington
Officer — EVP, CFO
Period of report
May 1, 2015
Accepted (ET)
May 5, 2015 · 7:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882095
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 1, 2015 | M | 11,250 | $24.295 | A | 38,974 | D | |
| Common Stock | May 1, 2015 | M | 5,592 | $40.56 | A | 44,566 | D | |
| Common StockF3 | May 1, 2015 | S | 2,200 | $103.4823 | D | 42,366 | D | |
| Common StockF4 | May 1, 2015 | S | 3,700 | $104.2278 | D | 38,666 | D | |
| Common StockF5 | May 1, 2015 | S | 5,742 | $105.3269 | D | 32,924 | D | |
| Common StockF6 | May 1, 2015 | S | 5,200 | $106.0219 | D | 27,724 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $24.295 | May 1, 2015 | M | 11,250 | D | — | Jan 26, 2022 | Common Stock | 11,250 | 33,750 | D |
| Non-Qualified Stock Option (right to buy)F2 | $40.56 | May 1, 2015 | M | 5,592 | D | — | Feb 1, 2023 | Commmon Stock | 5,592 | 39,158 | D |
Explanation of responses
- F1The sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- F2The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
- F3Sale prices reported for the transactions reported here range from $102.81 to $103.80. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- F4Sale prices reported for the transactions reported here range from $103.81 to $104.80. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- F5Sale prices reported for the transactions reported here range from $104.81 to $105.80. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- F6Sale prices reported for the transactions reported here range from $105.82 to $106.27. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.